Technology · Synbio & enabling tech / Genome engineering
Synthetic biology
The engineering of biology — designing DNA, cells and genetic circuits on computers, building them in biofoundries and scaling them into chemicals, materials and ingredients through the Design-Build-Test-Learn cycle.
1 · What it gives
Synthetic biology applies engineering discipline to living cells: it designs DNA, metabolic pathways and genetic circuits on a computer, builds them from synthesised genes in a biofoundry, tests the resulting strains at high throughput, and scales the best ones into chemicals, materials and food ingredients. The field runs on the Design-Build-Test-Learn (DBTL) cycle, where each iteration is automated and data-fed so that strain improvement compounds over time. Its toolkit spans gene synthesis, chassis organisms such as Escherichia coli and Saccharomyces cerevisiae, genetic logic circuits, and biocontainment systems (auxotrophy and kill switches) that keep engineered microbes inside the reactor. By 2026 the field is commercial at scale: Ginkgo Bioworks runs an industrial cell-programming foundry, Twist Bioscience supplies silicon-based synthetic DNA, Genomatica’s bio-BDO delivers 1,4-butanediol with 100% renewable carbon as a drop-in for nylon, and AMSilk’s recombinant spider-silk yarns reached consumer garments in 2026. The market is pulled by decarbonisation of heavy chemistry and by alternative-protein demand, but gated by GMO regulation, especially in the EU where synbio organisms fall under the precautionary GMO directive.
The key directions of synthetic biology are:
- Metabolic engineering of cell factories: redesigning microbial metabolism to convert sugar, CO2 or methanol into target molecules — drop-in chemicals, alternative proteins and speciality ingredients.
- Gene synthesis and biofoundries: high-throughput DNA synthesis and automated strain-building platforms that industrialise the Build phase of the DBTL cycle.
- Genetic circuits and programmable cells: logic-gene circuits that make cells sense signals and respond — biosensors, smart probiotics and cell therapies.
- Biocontainment and xeno-biology: kill switches, synthetic auxotrophy and recoded genomes that prevent engineered microbes from surviving or exchanging genes outside the reactor.
Sectoral value chain#
[Design: AI pathway & gene design] ──> [Build: DNA synthesis & foundry] ──> [Test: screening & fermentation]
│
(chassis cells: E. coli / yeast)
│
▼
[Purified product] <─── [Scale-up: demo bioreactor] <─────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Design | Computational design of the metabolic pathway and gene sequences, using AI/CAD tools to predict enzyme function and flux. | In: Genome data, AI models, target molecule spec. Out: DNA designs, pathway blueprints. |
| DNA synthesis & assembly | Silicon-based synthesis of genes and their assembly into pathways in an automated biofoundry. | In: DNA designs, synthesiser chips. Out: Assembled gene pathways, plasmids. |
| Strain construction | Introduction of the pathway into a chassis host (E. coli, yeast) and library generation of strain variants. | In: Pathways, chassis cells. Out: Variant strain libraries. |
| Screening & fermentation | High-throughput micro-fermentation and analytics screen variants for titre, rate and yield. | In: Strain libraries, feedstock. Out: Performance-ranked lead strains. |
| Scale-up | Transfer of the lead strain to pilot and demo bioreactors (hundreds to thousands of litres) to validate process economics. | In: Lead strains, bioreactors, feedstock. Out: Validated production process. |
| Product & downstream | Industrial fermentation and downstream purification into a commercial chemical, material or ingredient. | In: Production strain, feedstock, DSP train. Out: Purified biobased product. |
Cross-cutting technologies of the sector:
- Gene synthesis platforms: silicon-based DNA synthesis (Twist Bioscience) and cloud gene ordering industrialise the supply of synthetic DNA that feeds every build, cutting cost and turnaround.
- Automated biofoundries: robotic Design-Build-Test-Learn lines (Ginkgo Bioworks) run thousands of strain variants per cycle so improvement compounds with data.
- Genetic firewall biocontainment: synthetic auxotrophy, recoded genomes and kill switches restrict engineered microbes to the reactor, addressing the environmental-release risk that gates GMO approval.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1DesignData, software & automationComputational tools design the metabolic pathway and gene sequences for the target molecule, using AI and enzyme databases to predict function, flux and toxicity, and outputting a build-ready DNA design.Who can do this step matched automaticallyBota Bio 恩和生物 China✓ ISO 9001 600 tons pilot scale“Recent 2025-2026 developments include the launch of the SAION AI platform, a strategic partnership with Proya Cosmetics, and the 2026 market introduction of bio-identical Collagen …”163,050 tonnes“As the fundamental component of 5G deployment, optic fibre is critical to making Hong Kong a smart city and laying the groundwork for IoT.”India Glycols (NSE) India✓ ISO 9001 7,500 MT/ industrial scale“Even the administrative processes are green, where IGL has adopted the latest SAP ERP (S/4 HANA 2023 version), Salesforce CRM, Industrial IOT & other tech solutions to drive …”UMAMI Bioworks Singapore“Umami Bioworks (Singapore; address 89 Science Park Dr, 04-22) is a B2B cultivated seafood platform/licensing company that enables seafood producers to grow “not caught” species …”Metso Finland“With completely new and redesigned software,”
- 2BuildThe designed genes are synthesised on a silicon platform, assembled into pathways in an automated biofoundry, and prepared as construct libraries ready to transform a chassis host.
- 3Strain constructionStrains & cell linesThe pathway libraries are introduced into a chassis — E. coli or yeast — to generate thousands of strain variants, each a candidate cell factory whose performance must be measured.Who can do this step matched automaticallyPhaBuilder 微构工场 China30,000 tons/year industrial scale“Ultimately, it aims to realize the beautiful vision of “making PHA Life a lifestyle for thousands of households” and to implement the synthetic biology innovation path of …”Fermbox Bio India400 kilolitres industrial scale“Fermbox Bio is a Synthetic Biology Research and Manufacturing company developing and delivering sustainable Synbio products with improved scalability and speed.”Bota Bio 恩和生物 China✓ ISO 9001 600 tons pilot scale“By integrating end-to-end capabilities in AI, synthetic biology, and industrialization, Bota pioneers a new paradigm in biomanufacturing research and production.”Fermelanta Japan3,000 L pilot scale“is a Japan-based biomanufacturing/synthetic biology startup engineering fast-growing E.”
- 4TestTesting & analyticsHigh-throughput micro-fermentation and mass-spectrometry analytics screen the variant library for titre, rate and yield, ranking strains and feeding the data back into the next design cycle (Learn).Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”
- 5Scale-upContract manufacturing (CMO/CDMO)The lead strain is moved to pilot and demonstration bioreactors to validate mixing, gas transfer and process economics, and to lock the downstream purification train before industrial rollout.Who can do this step matched automaticallyCell AgriTech Malaysia5,000 L industrial scale“At Cell AgriTech, we position ourselves as Asia’s first dedicated CDMO for cultivated meat and plant cell culture.”Lotte Chemical South Koreaindustrial scale“Songdo CDMO Competition Begins - The Asia Business Daily — Lotte Biologics (not Lotte Chemical) is advancing its Songdo Plant 1 to GMP-Ready by November to enter Korea’s …”Esco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”
- 6Industrial fermentation and productFermentation & cultivationAt commercial scale the production strain ferments feedstock into the target molecule, which is recovered and purified to a biobased chemical, material or ingredient — sold as a drop-in replacement for the petrochemical or animal-derived original.Who can do this step matched automatically✓ ISO 9001 500 m3“Technology: microbial fermentation with ~500 m3 fermentation capacity; 15+ patents; developed/upscaled probiotic production technologies.”Spiber Japan✓ ISO 9001 industrial scale“By harnessing the power of precision fermentation, Spiber engineers proteins at the molecular level, resulting in versatile materials that can be tailored to specific needs.”PhaBuilder 微构工场 China30,000 tons/year industrial scale“[公司介绍 - 微构工场 — Microconstruct Farm (微构工场) focuses on biomanufacturing of PHA (polyhydroxyalkanoates), a green biopolymer.”Fermbox Bio India400 kilolitres industrial scale“Fermbox Bio is an active Bengaluru-based synthetic biology and precision fermentation company founded in 2022 by Subramani Ramachandrappa and Preeti Dharmagoudar.”Cell AgriTech Malaysia5,000 L industrial scale“We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”Bota Bio 恩和生物 China✓ ISO 9001 600 tons pilot scale“Bota Biosciences is a global leader in Physical AI-driven biomanufacturing, dedicated to making biotechnology a reliable and scalable engine of productivity.”
4 · Who delivers
Matched suppliers (matched automatically)
| Ginkgo Bioworks | United States | Producer | active |
| Novonesis | Denmark | Producer | active |
| Bota Bio 恩和生物 | China | Producer | active |
| Tsingke Biotechnology | China | Producer | active |
| Tidetron Bioworks 态创生物 | China | Producer | active |
| ImpacFat | Singapore | Producer | active |
| PhaBuilder 微构工场 | China | Research / RTO | active |
In the services and supply catalogue 1 · paid service
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Ginkgo Bioworks | 🇺🇸 USA | Foundry (cell programming) | Automated DBTL strain-engineering platform | commercial |
| Twist Bioscience | 🇺🇸 USA | Synthetic DNA / Clonal Genes | Silicon-based DNA synthesis; Complex Genes (2026) | commercial |
| Genomatica | 🇺🇸 USA | GENO Bio-BDO | 1,4-butanediol from plant sugar; 100% renewable carbon | commercial |
| AMSilk | 🇩🇪 Germany | Biosteel spider-silk yarns | 100% protein-based; consumer garments from 2026 | commercial |
| Cathay Industrial Biotech | 🇨🇳 China | Long-chain dibasic acids | Engineered microbes for biobased polymer monomers | commercial |
| Novonesis | 🇩🇰 Denmark | Biosolutions | Biosynthesis, enzymes and biosolutions for industry | commercial |
5 · Rules & route to market
United States
The United States leads synthetic biology through its foundry platforms, DNA-synthesis industry and a regulator that distinguishes engineered microbes under TSCA while funding the field as a national bioeconomy priority.
Ginkgo foundry, Twist DNA synthesis, bioeconomy EO#
- Ginkgo Bioworks and the foundry model: Ginkgo runs an industrial cell-programming platform that partners across food, agriculture and chemicals, automating the Design-Build-Test-Learn cycle for customers who buy strains rather than build them.
- Twist Bioscience and DNA supply: Twist manufactures synthetic DNA on a silicon platform and in 2026 launched Complex Genes (early access) for challenging repeat-rich sequences, feeding every downstream build.
- Policy and funding: the 2022 bioeconomy executive order makes synthetic biology a national priority, with DARPA Living Foundries and DOE bioenergy programmes funding strain and pathway engineering.
European Union
The European Union develops synthetic biology for the Green Transition — decarbonising heavy chemistry and replacing petrochemicals — but under the strictest GMO regime, which pushes many startups toward US relocation.
AMSilk spider silk, Bio-BDO, precautionary GMO law#
- AMSilk and biomaterials: AMSilk produces 100% protein-based recombinant spider-silk yarns that reached consumer garments in 2026, and supplies lightweight biotech materials for aerospace and premium apparel.
- Biobased chemistry and alt-protein: chemical majors integrate synbio for bioplastics and drop-in monomers, while precision-fermentation startups program microbes for animal-free dairy and collagen.
- Precautionary regulation: under EU law synbio organisms are classified as GMOs (Directive 2001/18/EC) and face EFSA risk assessment; the EIC Accelerator funds startups to bridge the “valley of death” to a first demo plant.
China
China treats synthetic biology as a strategic industrial base, backing national foundries and listed cell-factory companies to displace petrochemicals and secure ingredient supply.
Cathay diacids, national foundries, Bioeconomy strategy#
- Cathay Industrial Biotech: Cathay engineers microbes to produce long-chain dibasic acids, a class of biobased monomers for polymers and lubricants, and is a flagship of China’s industrial-synbio push.
- National foundries and hubs: state investment backs genome-synthesis and strain-engineering platforms at Tianjin, Shanghai and Shenzhen, with Yeast 2.0 chromosome synthesis among the visible outputs.
- Regulation: engineered organisms fall under the 2021 Biosafety Law and MARA/MOST oversight, with gene-edited crops handled on a track separate from classical GMOs.
6 · Money: tenders & grants
Public R&D projects 2
Publicly funded research projects (US NSF, and EU, UK and other funders via OpenAIRE) whose title names this technology — matched by title, not reviewed; amounts as awarded, in the funder's currency. all funded projects →
| 2026 | Transforming Biorefinery Waste Streams into Phosphorus Resources through Synthetic Biology-Enabled Biocatalysis NSF · 2609666 | 523,447 USD |
| 2025 | Beginnings: Innovative, Immersive Training Program in Synthetic Biology and Biomanufacturing NSF · 2526100 | 999,850 USD |
7 · Tech stack & innovations
The synthetic-biology stack joins computational design, automated DNA building and biocontainment into an industrial workflow.
- Gene synthesis and biofoundries:
- Silicon-based DNA synthesis (Twist Bioscience) manufactures genes at scale, and Complex Genes extends synthesis to difficult repeat-rich and secondary-structure sequences that long blocked pathway builds.
- Foundry platforms (Ginkgo Bioworks) automate the Design-Build-Test-Learn cycle so thousands of strain variants are built and screened per cycle, turning strain engineering into a data-compounding industrial process.
- Metabolic engineering of cell factories:
- Pathways are redesigned into chassis hosts — E. coli and S. cerevisiae — to convert sugar, methanol or CO2 into target molecules; Genomatica’s bio-BDO delivers a drop-in 1,4-butanediol with fully renewable carbon for nylon and spandex.
- Cathay Industrial Biotech and Novonesis extend cell-factory production to long-chain dibasic acids and biosolutions, displacing petrochemical routes across polymer, lubricant and ingredient markets.
- Genetic circuits and biocontainment:
- Logic-gene circuits let cells sense a signal and respond — biosensors, smart probiotics that deliver therapeutics at a tumour, and optogenetic switches that control cell growth with light.
- Biocontainment systems — synthetic auxotrophy for non-standard amino acids, recoded genomes and kill switches — restrict engineered microbes to the reactor, the technical answer to the environmental-release risk that gates approval.
Where this appears 8 sources
Appears in 8 distinct sources across 2 regions, 2022–2026.
- directory listings 1
- policy documents 7
Regions: China · Global
- 2021: 0
- 2022: 22
- 2023: 11
- 2024: 22
- 2025: 22
- 2026: 11
- 2027: 0
Matched themes 2
合成生物 合成生物技术
Themes from forum programmes, policy documents and reports are mapped to technologies automatically and then reviewed; counts are distinct sources, not mentions, and are not a ranking. data sources and method → · Trending, not yet covered →
Sources 6 · 0 independent · 6 producer sites
Producers' own sites 6
- Ginkgo bioworks producer checked 2026-06-23 · link not kept
- Twist bioscience producer checked 2026-05-26 · link not kept
- Genomatica producer checked 2026-05-15 · link not kept
- Amsilk producer checked 2026-04-29 · link not kept
- Cathay industrial biotech producer checked 2026-06-26 · link not kept
- Novonesis producer checked 2026-05-05 · link not kept